Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Anti-cancer effects of blue-green alga Spirulina platensis, a natural source of bilirubin-like tetrapyrrolic compounds

R. Koníčková, K. Vaňková, J. Vaníková, K. Váňová, L. Muchová, I. Subhanová, M. Zadinová, J. Zelenka, A. Dvořák, M. Kolář, H. Strnad, S. Rimpelová, T. Ruml, R. J Wong, L. Vítek,

. 2014 ; 13 (2) : 273-83.

Jazyk angličtina Země Mexiko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15008290

Spirulina platensis is a blue-green alga used as a dietary supplement because of its hypocholesterolemic properties. Among other bioactive substances, it is also rich in tetrapyrrolic compounds closely related to bilirubin molecule, a potent antioxidant and anti-proliferative agent. The aim of our study was to evaluate possible anticancer effects of S. platensis and S. platensis-derived tetrapyrroles using an experimental model of pancreatic cancer. The anti-proliferative effects of S. platensis and its tetrapyrrolic components [phycocyanobilin (PCB) and chlorophyllin, a surrogate molecule for chlorophyll A] were tested on several human pancreatic cancer cell lines and xenotransplanted nude mice. The effects of experimental therapeutics on mitochondrial reactive oxygen species (ROS) production and glutathione redox status were also evaluated. Compared to untreated cells, experimental therapeutics significantly decreased proliferation of human pancreatic cancer cell lines in vitro in a dose-dependent manner (from 0.16 g•L-1 [S. platensis], 60 μM [PCB], and 125 μM [chlorophyllin], p<0.05). The anti-proliferative effects of S. platensis were also shown in vivo, where inhibition of pancreatic cancer growth was evidenced since the third day of treatment (p < 0.05). All tested compounds decreased generation of mitochondrial ROS and glutathione redox status (p = 0.0006; 0.016; and 0.006 for S. platensis, PCB, and chlorophyllin, respectively). In conclusion, S. platensis and its tetrapyrrolic components substantially decreased the proliferation of experimental pancreatic cancer. These data support a chemopreventive role of this edible alga. Furthermore, it seems that dietary supplementation with this alga might enhance systemic pool of tetrapyrroles, known to be higher in subjects with Gilbert syndrome.

000      
00000naa a2200000 a 4500
001      
bmc15008290
003      
CZ-PrNML
005      
20150310124414.0
007      
ta
008      
150306s2014 mx f 000 0|eng||
009      
AR
035    __
$a (PubMed)24552870
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a mx
100    1_
$a Koníčková, Renata $u Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
245    10
$a Anti-cancer effects of blue-green alga Spirulina platensis, a natural source of bilirubin-like tetrapyrrolic compounds / $c R. Koníčková, K. Vaňková, J. Vaníková, K. Váňová, L. Muchová, I. Subhanová, M. Zadinová, J. Zelenka, A. Dvořák, M. Kolář, H. Strnad, S. Rimpelová, T. Ruml, R. J Wong, L. Vítek,
520    9_
$a Spirulina platensis is a blue-green alga used as a dietary supplement because of its hypocholesterolemic properties. Among other bioactive substances, it is also rich in tetrapyrrolic compounds closely related to bilirubin molecule, a potent antioxidant and anti-proliferative agent. The aim of our study was to evaluate possible anticancer effects of S. platensis and S. platensis-derived tetrapyrroles using an experimental model of pancreatic cancer. The anti-proliferative effects of S. platensis and its tetrapyrrolic components [phycocyanobilin (PCB) and chlorophyllin, a surrogate molecule for chlorophyll A] were tested on several human pancreatic cancer cell lines and xenotransplanted nude mice. The effects of experimental therapeutics on mitochondrial reactive oxygen species (ROS) production and glutathione redox status were also evaluated. Compared to untreated cells, experimental therapeutics significantly decreased proliferation of human pancreatic cancer cell lines in vitro in a dose-dependent manner (from 0.16 g•L-1 [S. platensis], 60 μM [PCB], and 125 μM [chlorophyllin], p<0.05). The anti-proliferative effects of S. platensis were also shown in vivo, where inhibition of pancreatic cancer growth was evidenced since the third day of treatment (p < 0.05). All tested compounds decreased generation of mitochondrial ROS and glutathione redox status (p = 0.0006; 0.016; and 0.006 for S. platensis, PCB, and chlorophyllin, respectively). In conclusion, S. platensis and its tetrapyrrolic components substantially decreased the proliferation of experimental pancreatic cancer. These data support a chemopreventive role of this edible alga. Furthermore, it seems that dietary supplementation with this alga might enhance systemic pool of tetrapyrroles, known to be higher in subjects with Gilbert syndrome.
650    _2
$a zvířata $7 D000818
650    _2
$a protinádorové látky $x farmakologie $7 D000970
650    _2
$a bilirubin $x farmakologie $7 D001663
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a proliferace buněk $x účinky léků $7 D049109
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a glutathion $x metabolismus $7 D005978
650    _2
$a lidé $7 D006801
650    _2
$a techniky in vitro $7 D066298
650    _2
$a myši $7 D051379
650    _2
$a myši nahé $7 D008819
650    _2
$a oxidace-redukce $7 D010084
650    _2
$a nádory slinivky břišní $x metabolismus $x patologie $7 D010190
650    _2
$a rostlinné extrakty $x farmakologie $7 D010936
650    _2
$a reaktivní formy kyslíku $x metabolismus $7 D017382
650    12
$a Spirulina $7 D053545
650    _2
$a tetrapyrroly $x farmakologie $7 D045725
650    _2
$a transplantace heterologní $7 D014183
650    _2
$a xenogenní modely - testy protinádorové aktivity $7 D023041
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vaňková, Kateřina $u Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Vaníková, Jana $u Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Váňová, Kateřina $u Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Muchová, Lucie $u Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Subhanová, Iva $u Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Zadinová, Marie $u Institute of Biophysics, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Zelenka, Jaroslav $u Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
700    1_
$a Dvořák, Aleš $u Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Kolář, Michal $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
700    1_
$a Strnad, Hynek $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
700    1_
$a Rimpelová, Silvie $u Department of Biochemistry and Microbiology, Institute of Chemical Technology, Prague, Czech Republic.
700    1_
$a Ruml, Tomáš $u Department of Biochemistry and Microbiology, Institute of Chemical Technology, Prague, Czech Republic.
700    1_
$a J Wong, Ronald $u Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
700    1_
$a Vítek, Libor $u Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University, Prague, Czech Republic; 4th Department of Internal Medicine, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
773    0_
$w MED00172549 $t Annals of hepatology $x 1665-2681 $g Roč. 13, č. 2 (2014), s. 273-83
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24552870 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150306 $b ABA008
991    __
$a 20150310124650 $b ABA008
999    __
$a ok $b bmc $g 1065563 $s 891090
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 13 $c 2 $d 273-83 $i 1665-2681 $m Annals of hepatology $n Ann Hepatol $x MED00172549
LZP    __
$a Pubmed-20150306

Najít záznam

Citační ukazatele

Možnosti archivace